Prerpints.org logo
Preprint
Article

Green Synthesis of Cocos nucifera-Based Nanomaterials and Mechanistic Basis of Their Antimicrobial Action.

Altmetrics

Downloads

176

Views

56

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

31 January 2024

Posted:

01 February 2024

You are already at the latest version

Alerts
Abstract
Caused by pathogenic microorganisms, such as bacteria, parasites, fungi, among others, infectious diseases can spread directly or from one individual to another. According to the World Health Organization, these diseases are known to cause high mortality rates, severe burdens of disability and serious worldwide aftermaths. The inappropriate use of antibiotics in humans are the main origins of the development of drug-resistant pathogens, which reduce the efficacy of these therapies, thus accentuating the need to search for effective antimicrobials. Medicinal plants have served as starting material for the preparation of a number of antimicrobial agents. To this end, the present study highlights the green synthesis of Cocos nucifera-based nanomaterials and evaluation of the mechanistic basis of their antimicrobial action. Accordingly, Cocos nucifera extract was used to reduce different concentrations (5, 10 and 20 mM) of silver nitrate solution to afford silver nanoparticles (AgNPs). These entities were further incorporated onto activated carbons (obtained by chemical activation using sulphuric acid as activation agent) to generate the nanocomposites. The antimicrobial activity of the as-prepared nanomaterials was evaluated using the broth microdilution method, while, the antioxidant activity was assessed through standard methods, such as 2,2-diphenyl-1-picrylhydrazyl (DPPH), and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assays. Cytotoxicity of potent nanomaterials was assessed on Vero cells by spectrophotometric method. As a result, nanoparticles were successfully synthesized as evidenced by the color change of the solution from transparent to dark brown. Further characterization was carried out by UV-visible spectroscopy that showed an intense absorption spectrum at 433 nm. Fourier Transform Infrared Spectroscopy (FTIR) revealed the functional group moieties involved as a capping and reducing agent in the synthesis of AgNPs. The incubation of nanomaterials with selected bacterial and fungal strains led to significant inhibitory effects of these pathogens with minimum inhibitory concentrations ranging from 7.813 to 250 μg/ml. In antioxidant assays, the nanocomposites presented scavenging activities comparable to that of ascorbic acid. Cytotoxicity experiment revealed no toxic effects on the human mammalian cells Vero (range of selectivity indices: from >4 to >128). These results provide evidence of the implication of Cocos nucifera-based nanomaterials in targeting bacterial or fungal systems that mediate free-radical damage or by inhibiting the oxidative damage caused by selected bacteria and fungi, the most susceptible being Escherichia coli and Candida albicans, respectively.
Keywords: 
Subject: Medicine and Pharmacology  -   Pharmacology and Toxicology

1. Introduction

Infectious diseases spread from one person to another and are caused by pathogenic microorganisms, such as bacteria, fungi, and parasites, among others [1]. Infectious diseases are the most frequent diseases, representing an important cause of morbidity and mortality among the general population, particularly in developing countries [2]. Infectious diseases are predominant in African and Asian countries due to the most prevalent vulnerable population, poor hygienic conditions, inadequate funding, poor microbiology services, limited technical experts and scarce epidemiological data to better inform preventive and treatment strategies [3]. Bongomin et al. [4] reported that patients with compromised immune function are especially prone to fungal pathogens that accounted for at least 13 million infections and 1.5 million deaths in the world annually [4]. Annually, over 150 million severe cases of fungal infections occur worldwide, resulting in approximately 1.7 million deaths per year [5]. Data generated by the Global Action Funds for Fungal Infections (GAFFI), suggests an estimate of 47.6 million Africans suffering from fungal diseases [6]. In Cameroon, it is estimated that more than a million people are affected each year by serious fungal infection, among which 8.1% of cases of recurrent vulvovaginal candidiasis are reported in women aged 15 to 50 years [7]. On the other hand, deaths caused by bacterial infections accounted for more than 1 in 8 global deaths in 2019, with five pathogens (Staphylococcus aureus, Escherichia coli, Streptococcus pneumonia and Klebsiella pneumoniae) accounting for more than half of those deaths [8]. In 2019, bacterial infections caused most deaths in sub-Saharan Africa with an estimate of 230 deaths per 100,000 people [9]. Recently, AMvomo et al. [10] reported that out of 156 samples collected from the Jordan Hospital (Yaounde-Cameroon), 86 were cultured positive and 100 bacteria, including mostly Enterobacter cloacae (17%), Klebsiella pneumoniae (17%), Staphylococcus aureus (16%) and Escherichia coli (11%) were isolated [10]. The entry of bacterial and fungal microorganisms induce a generation of free radicals, such as reactive oxygen species (superoxide ion, hydrogen peroxide and hydroxyl radical) and reactive nitrogen species [11]. Whenever, the rate of these free radicals is high as a result of the imbalance between free radicals and the naturally occurring antioxidants, there is an occurrence of many cellular events that trigger certain diseases (atherosclerosis, cancer, cardiovascular diseases, diabetes, and high blood pressure, among others) due to oxidative stress. Moreover, the implication and contribution of oxidative stress in any pathological condition is undeniable [12]. Indeed, oxidative stress has intricately been involved in the pathogenesis of infectious diseases as the overproduction of resulting products (ROS and RNS) are potentially harmful to host cells and create a highly cytotoxic milieu thereby contributing to cell damage [13,14]. The concerted action of antioxidants to ameliorate the harmful effect of oxidative stress is achieved by antioxidant enzymes (Superoxide dismutases-SODs, catalase, glutathione peroxidase-GPx), and small molecular weight antioxidants (vitamins C and E, flavonoids, carotenoids, melatonin, ergothioneine, and others) [15].
Nowadays, various antimicrobial agents including antibiotics have been widely employed in treating diseases caused by these infectious pathogens. These include antifungal drugs, such as amphotericin B, fluconazole, itraconazole, voriconazole, and posaconazole [16], as well as antibacterial therapies like the fluoroquinolones (ciprofloxacin, moxifloxacin, norfloxacin, etc.), penicillins (amoxicilline, dicloxacillin, etc.), aminoglycosides (amikacine, gentamicin, tobramycine), and cephalosporins (ceftriaxone, céfépime, ceftazidime), and others. In severe or uncomplicated cases of bacterial or fungal infections, combination therapies would be recommended for bacterial (ceftriaxone-vancomycin; Leekha et al. [17]) and fungal (AmB-posaconazole; Campitelli et al. [18]) diseases. However, the misuse and/or excessive use of these antimicrobials has developed drug resistance, resulting in low treatment efficacy. The growing resistance of microbes to antibacterial and antifungal treatments, as well as their toxic effects, suggested imperatively to search for alternative remedies against these maladies [19]. Even though the antimicrobial drugs that possess antioxidant properties might help in the fight of microbial drug resistance, the side effects of these antioxidants (ethoxyquin and propyl gallate are carcinogenic, neurotoxic and hepatotoxic, etc.) are not negligible.
Medicinal plants have been used for several decades to cure a variety of diseases, including bacterial and fungal diseases [20]. In addition, contemporary medicines derive basically from herbs with reference to traditional knowledge and practices, and beliefs. According to the World Health Organization (WHO), more than 80% of the world's population relies on traditional medicine for their basic health care [21]. One such plant include Cocos nucifera, which is used for the traditional treatment of diarrhoea and stomach aches, and as a topic ointment for dermatitis, abscesses, and injuries, etc. [22]. On the other hand, modern chemistry and pharmacological studies have demonstrated the implication of active principles from diverse sources (especially, from plants) in the discovery of antimicrobial drugs [20,23]. For instance, previous reports have demonstrated the anti-inflammatory, anti-viral, anthelminthic, anti-leishmanial, antimalarial and hepatoprotective activities of Cocos nucifera [22].
Materials in the nanoscale range have been employed to deliver therapeutic agents to specific targeted sites in a well-ordered method [24]. These nanoparticles have created huge interest in a wide range of applications owing to their controllable size and shape along with excellent reactivity and unique physical, chemical, and biological properties [19]. Although metal-based nanoparticles have been reported to exhibit antimicrobial activity against a wide range of bacterial and fungal diseases [25,26,27], biocapping with plant extracts is an effective approach for the fabrication of nanoparticles with minimum toxicity [28,29]. More recently, new approaches have been developed to enhance the antimicrobial activity of nanoscale materials by tagging nanoparticles on the surface of activated carbon to acquire nanocomposites [30]. Moreover, it is well known that nanocomposites exhibit more efficient antibacterial activity than the nanoparticle counterparts [30].
Indeed, activated carbon (AC) is a porous material exhibiting amphoteric characteristics and is usually used for the adsorption of organic and inorganic compounds. Additionally, activated carbon have the ability to adsorb bacteria, fungi, toxins and other chemicals [31]. Based on the foregoing, there is evidence that biologically synthesized nanomaterials (nanoparticles and nanocomposites) can afford potentially active antimicrobial compounds that might serve as a baseline for the discovery of effective antimicrobial agents. Thus, the present study aims to green synthesis of Cocos nucifera-based nanomaterials and study of the mechanistic basis of their antimicrobial action. The cytotoxicity of the active antimicrobial nanoparticles is also evaluated against the human mammalian cells Vero.

2. Material and methods

2.1. Material

Shells of Cocos nucifera (coconut shells) were obtained from coconut vendors in the local Melen market, Mfoundi Division, Centre Region of Cameroon. These shells were brought to the Physical and Theoretical Chemistry Laboratory of the University of Yaoundé 1 and used for the preparation of activated carbon and nanomaterials. The coconut shells were washed to remove dirt and other contaminants, then dried to remove water and moisture. Next, the shells were ground mechanically using a Retsch Pulverisette grinder and sieved to sizes varying between 0-1.25 mm and 1.25-2.5 mm, then stored at room temperature for further use.

2.2. Preparation of the activated carbon

The activated carbon was prepared according to a previously reported method by Naphtali Odogu et al. [32]. Ten grams (10.0 g) of the ground coconut shells were impregnated with H2SO4 (98 %) solution of impregnation ratio 0.5. The mixture was kept for 1 hour at room temperature, so that reagents are fully absorbed into the shells’ network. The impregnated sample were dried at 110 °C for 24 hours in an oven. The dried impregnated samples were cooled in a desiccator for 1 hour and carbonised using a Carbolite Furnace at a temperature of 432 °C for 40 minutes. The activated carbon (AC) obtained was washed with distilled water.

2.3. Synthesis and characterisation of silver nanoparticles

Silver nanoparticles (AgNP) were prepared using aqueous coconut shell extract as the reducing agent and the silver nitrate (AgNO₃) as the precursor reagent as per a standard protocol reported by Das et al. [33] with minor modifications (by using 5, 10 and 20 mM of AgNO₃ in lieu of 1mM of AgNO₃). Briefly, 10.0 g of the powder coconut shells was mixed with 100 mL of distilled water, then stirred using a magnetic stirrer for 30 minutes, and filtered. Next, about 100 ml AgNO₃ (5, 10 and 20 mM) was taken in 3 separate sets of the conical flask (250 ml) and then the addition of coconut shell solution (10 ml) was effected with constant stirring in a magnetic stirrer. The silver nanoparticle thus synthesised was characterised using ultraviolet–visible (UV-Vis) spectroscopy and Fourier Transform Infrared Spectroscopy (FTIR).

2.4. Preparation of silver nanocomposite

The nanoparticles (AgNPs) were loaded on the activated carbon by simple agitation. In brief, 5.0 g of activated carbon was added to the as-prepared AgNPs’ solution. Then, the mixture was stirred continuously for 1 hour at 150 rpm using Horse shoe IKA agitator. The nanocomposite (AgNC) was further obtained by drying the AgNP loaded activated carbon powder in an oven ((Bluepard Instruments Co. Ltd, Shanghai) at 110 °C.

2.5. Antimicrobial assay

2.5.1. Microbial species and culture media

As summarized on Table 1, eight bacteria species were used in this study: one strain (Klebsiella pneumoniae NR 41817, Pseudomonas aeruginosa NR 48982, Shigella flexneri NR 518, Shigella sonnei NR 519 were obtained from the Biodefense and Emerging Infections Research Resources Repository (BEI Resources, Rockville, MD 20,852), whereas Escherichia coli (ATCC 25922) and Staphylococcus aureus (ATCC 43310 and ATCC 33591) was obtained commercially from the American Type Culture Collection (ATCC, Manassas, VA, USA). Moreover, Salmonella enteritidis (CPC) obtained from the Centre Pasteur of Cameroon. In addition, five fungal species, including Candida albicans (CA NR-29456), Candida glabrata (CG 100), and Candida parapsilosis (CP O31S) (obtained from BEI Resources), and Candida albicans (CA ATCC-14516), and Candida krusei (CK ATCC-1415) (obtained from ATCC) were also used in this study.

2.5.2. Determination of minimum inhibitory concentrations

The minimum inhibitory concentrations (MICs) of the as-prepared nanomaterials were determined by the broth microdilution method (in triplicate) on 96-well microplates according to the M07A3 and M07A9 protocols described by the Clinical Laboratory Standards Institute [34]. Briefly, 196 μL of Muller Hinton Broth and Saboraud Dextrose Broth (MHB/SDB) were separately introduced into the wells of the first line of microplate followed by the addition of 4 μL of different concentrations of nanomaterials (initially prepared at 100 mg/ml in distilled water). Next, two-fold serial dilutions were performed in the wells, and 100 μL of the bacterial (1.5 x108 CFU/mL) or fungal suspension (2.5 x103 CFU/ml) were added into each well. The final concentrations ranged from 1000 to 15.625 μg/mL for the nanomaterials and 2 to 0.0156 μg/mL for the positive controls (ciprofloxacin and fluconazole for antibacterial and antifungal tests, respectively). Then, the plates were incubated at 37˚C for 24 hours and 4hours for bacterial and fungal strains, respectively, followed by an addition of 20 μL of 0.015 mg/mL resazurin solution (0.15 mg/mL in phosphate buffer saline, PBS) (Sigma-Aldrich, Darmstadt, Germany) and 30 minutes incubation at 37˚C. The minimum inhibitory concentrations (MICs) were determined as the lowest concentrations of nanomaterials or standard drugs at which no visible color change (from blue to pink) was observed. Wells containing MHB and bacteria, or SDB and fungi constituted the negative control, for antibacterial and antifungal tests, respectively, while the sterility controls contained only MHB, and SDB.

2.6. Time-kill kinetics test.

The time kill kinetic study of the most active nanoparticles and nanocomposites was performed on E. coli according to the method described by [21]. Herein, the active nanomaterials were prepared at various concentrations (MIC, 2MIC and 4MIC), by two-fold serial dilutions in a 96 well micro-plate. One hundred microliters (100 μL) of E. coli suspension (1.5 x 10⁶ CFU/mL) were added to the preparations, and the plate was subsequently incubated at 37˚C at different time intervals (0, 1, 2, 4, 6, 8, 12, and 24 h). Following each incubation period, optical densities (OD) were read using a microtitre plate reader (TECAN Infinite M200, Männedorf, Switzerland). The values obtained (optical densities) were used to draw a graph, i.e. OD versus incubation time at 630 nm.

2.7. Cytotoxicity assays

As previously reported by Bowling et al. [35], the cytotoxicity of the most active nanomaterials was assessed by the resazurin colorimetric method, using the human mammalian cells Vero (ATCC CRL 1586), which were generously obtained from the Centre Pasteur of Cameroon (CPC). The Vero cells were cultured in complete medium containing 0.5% MEM (Gibco, Waltham, MA USA), 13.5 g/L DMEM (Gibco, Waltham, MA USA), 10% fetal bovine serum (Gibco, Waltham, MA USA), 0.21% bicarbonate (Sigma-Aldrich, New Delhi, India), and 10 mL (1%) of penicillin/streptomycin antibiotics. The cytotoxicity test was performed in triplicate on 96 well cell cultured treated microplates. In brief, 100 µL cell suspension, which was titrated at 5×103 cells/well was introduced into the wells of a microplate 4 hours, prior to exposure with the most active nanomaterials to allow adhesion and cell confluence. Subsequently, the nanomaterials (100 µL), which were prepared at different concentrations were introduced into the wells containing the adherent cells, and further incubated for 48 hours at 37°C in a humidified atmosphere with 5 % CO2. The positive control and negative control wells contained podophyllotoxin at 10 µM and cells without nanomaterials, respectively. Afterwards, 10 µl of a solution of resazurin (0.15 mg/ml in PBS) was added into each well, and then incubated for an additional 4 hours. Fluorescence of the obtained preparation was measured at excitation and emission wavelengths of 530 and 570 nm, respectively, by using a microtitre plate reader (TECAN Infinite M200, Männedorf, Switzerland). From the resulting values of optical densities, the percentage of cell viability was calculated with Microsoft excel software using the following formula:
(At − Ab)
% cell viability = ------------ × 100
(Ac − Ab)
Where, At=Absorbance of test sample, Ab=Absorbance of the positive control podophyllotoxin, Ac=Absorbance of negative control (cells).
A dose-response curve (percentage of cell viability versus concentration of the nanomaterials) was plotted using graph pad prism software, to determine the median cytotoxic concentrations (CC50s) of the test samples.

2.8. In vitro antioxidant activity

The antioxidant activity of the most active nanomaterials was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical scavenging assays.

2.8.1. DPPH radical scavenging assay

A previously described protocol by Bassene [36] was used to evaluate the potential of the most active nanomaterials as scavenger of the free radicals of DPPH. Briefly, different concentrations (2000, 1000, 500, 250, 125, 62.5, 31.25, and 15.625 μg/mL) of the nanomaterials were prepared in a 96 well microplate. Next, twenty-five microliters (25 μL) of each solution was introduced into a fresh microplate, followed by an addition of 75 μL of 0.02% DPPH to achieve final concentrations of 500, 250, 125, 62.5, 31.25, 15.625, 7.813 and 3.906 μg/mL. The reaction mixtures were kept in the dark at room temperature for 30 min, then the absorbance was measured at 517 nm against the blank (DPPH in methanol) using a microtitre plate reader (TECAN Infinite M200, Männedorf, Switzerland). L-ascorbic acid (concentration range: 25-0.195 μg/mL) was used as the positive control. The assay was performed in triplicate, and the percentage (%) radical scavenging activities of the test samples were calculated using the following formula:
%   RSA = A o − A s A o x 100
Where, RSA: Radical Scavenging Activity; Ao: Absorbance of the blank; As: Absorbance of test sample.
The radical scavenging activity 50 (RSA50), effective concentration 50 (EC50), and antiradical power (ARP) were further deduced from the % RSA.

2.8.2. ABTS radical scavenging assay

A previously described method by Khan et al. [37] was used to assess the scavenging potential of the active antibacterial nanomaterials vis-à-vis free radicals of ABTS. In short, different concentrations (2000, 1000, 500, 250, 125, 62.5, 31.25, and 15.625 μg/mL) of the active nanomaterials were prepared in a 96 well microplate. Then, 25 μL of each solution was introduced into another microplate, followed by an addition of and 75 μL of 0.02% ABTS to obtain final concentrations of 500, 250, 125, 62.5, 31.25, 15.625, 7.813 and 3.906 μg/mL. After 30 minutes’ incubation at room temperature in the dark, the absorbance was read at 734 nm against the blank (ABTS in methanol) by using a microtiter plate reader (TECAN Infinite M200, Männedorf, Switzerland). L-ascorbic acid (concentration range: 25-0.195 μg/mL) was used as the positive control. The assay was performed in triplicate, and the percentage (%) of radical scavenging activities of test samples were calculated using the following formula:
%   RSA = A o − A s A o x 100
Where, RSA: Radical Scavenging Activity; Ao: Absorbance of the blank; As: Absorbance of test sample.

2.9. Statistical analysis

Wherever appropriate, the data were subjected to one-way analysis of variance (ANOVA) and results were presented as the Mean ± SD of the replicated values. Significant differences for multiple comparisons were determined by Dunnet test at P≤0.00.1 MIC and CC50 values were obtained as already discussed from the graphs plotted using Graph Pad prism version 8.0 (version 2013, Washington, DC, United States of America). Graphical evaluation of the data was done using Microsoft Excel 2016.

3. Results and discussion

3.1. Results

3.1.1. UV–visible spectral analysis

A biological synthesis of silver nanoparticles was successfully achieved using aqueous extract of Cocos nucifera shells with silver nitrate (AgNO3) solution at various concentrations (5, 10 and 20 mM) (Figure 1). The formation of the nanoparticle was evidenced by a gradual color change (from colourless to dark brown) that was observed. The fabrication of the AgNPs was further confirmed by UV-vis visible spectroscopy in the wavelength range of 350-900 nm (Figure 2). The absorption spectrum of the prepared silver nanoparticles showed surface Plasmon resonance and exhibited a λmax at 433 nm confirming the synthesis of the nanoparticles.

3.1.2. FTIR analysis of synthesized nanomaterials

The FT-IR spectra of Cocos nucifera extract and nanoparticles (A), and activated carbon and nanocomposites (B) are presented in Figure 3. The Cocos nucifera extract displayed four adsorption peaks at 3297.338, 2923.413, 1643.004, and 1237.918 cm-1. The band at 3297.338 cm-1 is due to the absorption of water molecules as result of an O-H stretching mode of hydroxyl groups and adsorbed water. A vibration band at 2923.413 cm-1 is attributed to the presence of methylene groups (C-H). Also, 1643.004 cm-1 band is attributed to a carbonyl (C=O) of esters and carboxylic acid, meanwhile the adsorption band at 1237.918 cm-1 corresponds to an ether stretch (C-O-C). The vibration band around 999.966 cm-1 represent the C-C bonds in the fingerprint region. After activation and carbonization, there is the disappearance of some peaks in the FTIR spectra of the AgNP and considerable decrease in the intensity of some peaks as seen in Figure 3A. The peaks around 3297.338 and 1643.004 superimpose with those of AgNP. However, there is an outstanding similarity in the spectra of both AC and CNS. The band at 3264.76cm-1 is attributed to the O-H bond stretching vibration of absorbed water molecules. The vibration band at 1643.004 cm-1 is attributed to the carbonyl group (C=O) of esters and carboxylic acid.

3.1.3. Minimum inhibitory concentrations of the as-prepared nanomaterials

a. MIC values of nanomaterials on selected bacteria
The incubation of different bacterial strains with various concentrations of nanoparticles (AgNP) led to a significant inhibition of the bacterial growth as evidenced by the low MIC values obtained (Table 2). In fact, the MIC values ranged from 15.625 to 62.5 µg/ml, 15.625 to 31.25 µg/ml and 7.8125 to 31.25 µg/ml at 5, 10 and 20 mM, respectively. Similarly, the nanocomposite (AgNC) exhibited a significant antibacterial activity against the tested bacteria with MIC values ranging from 62.5 to 250 µg/ml, 31.25 to 250 µg/ml and 31.25 to 62.5 µg/ml at 5, 10 and 20 mM, respectively, vs ciprofloxacin (MIC range: 0.039-0.156 µg/ml) (Table 2). Among the bacterial strains tested, E. coli was the most susceptible strain (for both nanomaterials), whereas Salmonella enteritidis (for the nanoparticle), and methicillin resistant Staphylococcus aureus, Klebsiella pneumoniae and Shigella sonnei (for the nanocomposite) were the most resistant bacterial strains.
b. MIC values of nanomaterials on selected fungi
Table 3 summarizes the minimum inhibitory concentrations (MICs) of the nanomaterials against selected fungi. The incubation of fungal strains with various concentrations of nanocomposite for 48 hours has resulted in the inhibition of fungal growth with minimum inhibitory concentrations (MICs) ranging 31.25 to 125 µg/ml, 62.5 to 250 µg/ml, and 31.25 to 62.5 µg/ml at the concentrations of 5, 10 and 20 mM, respectively, vs fluconazole (MIC range: 0.153-0.3825 µg/ml). Likewise, the treatment of fungal strains with various concentrations of nanoparticles (5, 10 and 20 mM) has resulted in the inhibition of tested fungi with minimum inhibitory concentrations ranging from 62.5 to 250 µg/ml, 62.5 to 250 µg/ml, and 31.25 to 62.5 µg/ml at 5, 10 and 20 mM, respectively, vs fluconazole (MIC range: 0.153-0.3825 µg/ml). Among the fungi tested, the most susceptible was found to be Candida albicans (MIC range: 7.812-31.25 µg/ml).

3.4. Time-kill kinetics

3.4.1. Time-kill kinetics in Escherichia coli

Since E. coli was found to be the most susceptible bacteria, the inhibitory potential of the nanomaterials was followed up at different time intervals for a period of 30 hours at MIC/2, MIC and 2MIC. As a result, 8 to 10 hours’ incubation of E. coli along with MIC-based concentrations of nanomaterials (nanoparticle and nanocomposite) showed significant bacterial growth inhibition as evidenced by a marked decrease of the bacterial growth curves of test samples compared to the negative control without treatment (Figure 4A,B) from 10 to 30 hours of incubation time period, the bacterial population significantly decreased as shown by the curves’ inclination towards the X axis. Similar trend was better observed with the standard drug ciprofloxacin (Figure 4A,B). These results demonstrate the bactericidal orientation of the nanomaterials at MIC and 2MIC.

3.4.2. Time-kill kinetics in Candida albicans

Since Candida albicans was found to be the most susceptible fungus, the inhibitory potential of the nanomaterials was followed up at different time intervals for a period of 48 hours at MIC/2, MIC and 2MIC. As a result, 8 to 10 hours’ incubation of C. albicans along with MIC-based concentrations of nanomaterials (nanoparticle and nanocomposite) showed significant inhibition of fungal growth as evidenced by a marked decrease of the fungal growth curves of test samples compared to the negative control without treatment (Figure 5A,B). From 10 to 48 hours of incubation time period, there was a slight growth of the fungal population as shown by the curves’ inclination, which tends to be horizontal within the time period considered. Similar trend was observed with the standard drug fluconazole (Figure 5A,B). These results demonstrate the fungistatic inclination of the nanomaterials at MIC and 2MIC.

3.5. Cytotoxicity assay

The cytotoxicity of the nanomaterials (nanoparticle and nanocomposite) was assayed on the human mammalian cells Vero. As a result, the incubation of nanocomposite with Vero cells did not affect the viability of the mammalian cells as the median cytotoxic concentrations (CC50) was calculated as >1000 µg/ml at all the concentrations (5, 10, and 20 mM) tested. On the other hand, the incubation of the nanoparticle (AgNP) at 5 and 10 mM with the Vero cells did not cause any toxic effect on the cells because the CC50 values obtained were >1000 µg/ml; however, 20 mM concentration of the AgNP revealed mild cytotoxicity toward Vero cells as the CC50 value obtained was as low as 60.52 µg/ml. Meanwhile podophyllotoxin, the standard cytotoxic agent, yielded CC50 value of 0.4 µg/ml (Table 4).

3.6. Antioxidant activity

3.6.1. The DPPH scavenging assay

The DPPH assay revealed that 5 mM nanoparticle exhibited free radical scavenging activity with RS50 value of 382.5 ± 3.323 µg/mL, vs ascorbic acid (RS50 value: 7.363 µg/mL) (Table 4). Similar trends were observed for the median effective concentration (EC50) (5 mM nanoparticle: 754.038 mol/µg, vs ascorbic acid, 21.556 µg/mol) and antiradical potential (ARP) (5 mM nanoparticle: 198.529 mol/µg, vs ascorbic acid, 104.46 mol/µg) (Table 4).
Table 4. DPPH radical scavenging activities of the nanomaterials.
Table 4. DPPH radical scavenging activities of the nanomaterials.
Nanomaterials/ascorbic acid RSA50 (µg/mL) - EC50 x 103 (µg/mol) - ARP x 10-6 - (mol/µg) -
AgNC 5mM >500 na na
AgNC 10mM >500 na na
AgNC 20mM >500 na na
AgNP 5mM 382.5 ± 3.323ᵇ 754.038 ± 6.552ᵇ 198.529 ± .0115ᵇ
AgNP 10mM >500 na na
AgNP 20mM >500 na na
Ascorbic acid 7.363 ± 0.312 a 21.556 ± 0.615 a 104.46 ± 2.92 a
Along the line, values carrying the same letter superscripts are not significantly different (P≤0.001), Dunnett's multiple comparisons test. AgNC 5mM: 5mM silver nanocomposite; AgNC 10 mM: 10 mM of silver nanocomposite; AgNC 20mM: 20 mM of silver nanocomposite; AgNP 5 mM: 5 mM of silver nanoparticle; AgNP 10 mM: 10 mM of silver nanoparticle; AgNP 20 mM: 20 mM of silver nanoparticle, na: no activity.

3.6.2. The ABTS scavenging test

In ABTS assay, the nanocomposite showed significant antioxidant activity at all the concentrations tested (5, 10, and 20 mM) (Table 5). At 10 and 20 mM, the nanocomposite exhibited better radical scavenging activities (RS50 values: 8.2695 and 6.586 µg/mL) than ascorbic acid (RS50 value: 22.46 μg/mL). In addition, 5 mM nanocomposite presented significant antioxidant activity (RS50 value: 53.855 μg/mL), even though the degree of the activity was less than that of ascorbic acid (RS50 value: 22.46 μg/mL). The nanoparticle did not reveal significant ABTS scavenging activity at all the concentrations tested (RS50: >500 µg/mL). In addition, the median effective concentrations (EC50s) were found to be 15.387, 2.362 and 1.883 µg/mol at 5, 10, and 20 mM of nanocomposite, respectively. Moreover, the antioxidant radical potentials (ARP) were obtained as 6.619, 41.704, and 55.055 mol/µg at 5, 10 and 20 mM of nanocomposite, respectively, vs ascorbic acid (ARP: 15.699 mol/µg) (Table 5).

4. Discussion

In this study, the aqueous extract of Cocos nucifera was used as a reducing and stabilizing agent for the bio-fabrication of silver nanoparticles. After preparing an activated carbon from this plant species, the as-prepared nanoparticles were loaded on activated carbon by simple impregnation to afford the nanocomposite. As it is essential that these materials be thoroughly characterized to ensure reproducibility in their fabrication, UV-vis spectrometry and FTIR analyses were used for the characterization of the as-prepared nanomaterials. As a result, the nanoparticles presented λmax value at 432 nm, which confirmed the synthesis of the nanoparticles as it is well known that silver nanoparticles are formed at λmax values within the visible range of 400-500 nm [38,39,40]. This result is consistent with a study by Das et al. [33] who recently prepared coconut shell-based silver nanoparticles that displayed a maximum absorbance at 447 nm. The color change from colorless to dark brown was due to the presence of Ag nano-dot embedded organic light emitting diode by localized Surface Plasmon Resonance [41,42]. The intensity of the peaks shows the crystalline nature of the nanoparticles. A number of authors [43,44] have identified several phenolic compounds in Cocos nucifera shells, which compounds might have contributed to the reduction of and stabilization of prepared nanoparticles. The FTIR analysis of Cocos nucifera aqueous extract, activated carbon, and the nanomaterials revealed a number of functional groups present at the surface of these materials. For instance, the main surface functional groups present in C. nucifera aqueous extract were a combination of hydroxyl (OH), methylene , carbonyl (C=O), and ether (C-O-C) groups as evidenced by the report of Sulaeman and coworkers in 2016 [45]. As the C. nucifera aqueous extract is converted into silver nanoparticle using silver nitrate, there is a gradual change in the composition of the functional groups. For instance, there was a marked shift of peaks in the chromatogram of synthesized silver nanoparticles [26,46,47]. After activation and carbonization, all the functional groups present in the C. nucifera precursor disappeared due to decomposition of cellulose, hemicellulose and lignin during the carbonization process [48]. The disappearance of functional groups from the CNS to the activated carbon (AC) shows the effect of temperature and activating agent during the preparation of the AC. Nanoparticles and nanocomposites were further evaluated for antimicrobial activity against selected bacterial and fungal strains. As a result, these nanomaterials inhibited the growth of bacteria and fungi with MIC values ranging from 7.813 to 500 μg/mL. The most susceptible microorganisms were found to be Escherichia coli and Candida albicans among bacteria and fungi, respectively. It is worth noting that Cocos nucifera aqueous extract, activated carbon did not reveal antimicrobial activity (MIC>1000 μg/mL) (data not shown); however, the role of these entities in the fabrication of nanomaterials with reduced toxicity and the enhancement of the antimicrobial activity is undeniable [33,47]. Through their small diameter, activated carbons efficiently bind onto microbes by adsorption to yield better or enhanced bactericidal property [49,50]. Other features of activated carbons include high porosity, high specific surface area, and desired surface functionalization [47,51]. Although there is almost no standard reported threshold values for antimicrobial nanomaterials to ascertain their degree of activity, it is generally known that the less is the MIC values of the test samples the more is the antimicrobial activity. Other authors have speculated that very active and active antimicrobial plant extracts should exhibit MIC values < 100 μg/mL and 100 ≤MIC ≤512 μg/mL, respectively [52,53]. Cytotoxic studies of 5 and 10 mM of the nanomaterials on the human mammalian cells Vero revealed no toxic effect as evidenced by the median cytotoxic concentration (CC50: >1000 μg/mL). At 20 mM concentration, the nanocomposite was not found to be toxic to Vero cells, whereas the nanoparticle showed mild cytotoxicity (CC50: 60.52 μg/mL) at this concentration. This observation might justify the plausible toxicity of nanoparticles over their nanocomposite counterparts. These results demonstrated that the antibacterial (SI: >16 to >32 and >16 to >128 for nanoparticle and nanocomposite, respectively) and antifungal (SI: >4 to >16 and >16 to >32, for nanoparticle and nanocomposite, respectively) nanomaterials revealed high selectivity indices, thus highlighting the non-toxicity of these entities.
The kinetic of bacterial deaths, which was further evaluated revealed a bactericidal orientation of the nanomaterials at MIC and 2MIC on E. coli as evidenced by the trend of the curves obtained while plotting optical densities versus time of incubation. This observation helps to conclude about a putative mode by which Cocos nucifera-based nanomaterials affected the bacterial growth. Indeed, there was a direct killing of bacteria for the overall period of incubation (30 hours) studied rather than an ephemeral inhibition of bacterial growth. It is worth nothing that a decrease in the absorbance indicates a reduction of the bacterial population that might have resulted in the death of cells [54]. On the other hand, since Candida albicans was found to be the most susceptible fungus strain, the inhibitory potential of the nanomaterials was followed up at different time intervals for a period of 48 hours at MIC/2, MIC and 2MIC. As a result, 8 to 10 hours’ incubation of C. albicans along with MIC-based concentrations of nanomaterials showed significant fungal growth inhibition as evidenced by a marked decrease of the curves of test samples compared to the negative control without treatment (Figure 5A,B). From 10 to 48 hours of incubation time period, there was a slight growth of the fungal population as shown by the curves’ inclination, which tends to be horizontal within the entire time period considered. A similar trend was observed with the standard drug fluconazole (Figure 5A,B). These results demonstrate the fungistatic orientation of the nanomaterials at MIC and 2MIC.
Furthermore, the antimicrobial activity of nanoparticles has been attributed to three main mechanisms of action, including (i) adhesion onto the outer membrane, accumulation in the inner membrane, increase of membrane permeability, leakage of cell content followed by cell death; (ii) interaction with sulphur and phosphate groups of the DNA (deoxyribonucleic acid) and proteins to alter their functions; (iii) interaction with cellular components to alter the metabolic pathways, membranes, and genetic material, among others.
As the oxidative stress is intricately involved in any pathological condition, including infectious disease conditions, antioxidant activity of the nanomaterials was evaluated to further detail whether the potential antioxidant activity of the nanomaterials might have contributed to their antibacterial action. In DPPH assay, 5 mM of the nanoparticle showed antiradical activity, whereas in ABTS test, the nanocomposite showed scavenging activity at all the concentrations tested (5, 10 and 20 mM). Several authors attributed the antioxidant activity of plant extracts or nanomaterials thereof to their abundance in a variety of polyphenols that are endowed with a high reducing capacity [55,56,57]. Both the nanomaterials revealed antioxidant activity, attesting their implication in a plausible reduction of oxidative stress following microbial infection. Accumulating evidence has shown the involvement of oxidative stress in the pathogenesis of several diseases [12,58], thus, the intervention of antioxidants during an infectious condition might prevent cell damage induced by oxidative stress.
Overall, Cocos nucifera-based nanomaterials were fabricated using an eco-friendly method. UV-vis and FTIR analyses are used to characterize these nanomaterials, which further exhibited concentration-dependent antibacterial and antifungal activities with no cytotoxic effects toward the human mammalian cells Vero. The mechanistic basis of the antibacterial action revealed a bactericidal orientation of the nanomaterials on Escherichia coli at MIC and 2MIC, whereas the antifungal action displayed a fungistatic inclination on Candida albicans at these concentrations, possibly, through inhibition of the free radicals produced by the bacteria or fungi. This novel contribution has demonstrated the involvement of Cocos nucifera-based nanomaterials in targeting bacterial or fungal systems that mediate free-radical damage or by inhibiting the oxidative impairment caused by selected bacteria and fungi.

5. Limitations and perspectives

The present study summarizes a preliminary screening of the antimicrobial action of nanoscale materials from Cocos nucifera aqueous extract. Cocos nucifera-based nanoparticles and nanocomposites exhibited antibacterial and antifungal activities against a panel of selected bacteria and fungi, the most susceptible being Escherichia coli and Candida albicans, respectively. In addition, the mechanistic basis of the antibacterial action demonstrated that the nanomaterials induced (i) bactericidal orientation vis-à-vis E. coli at MIC and 2MIC, (iii) fungistatic inclination against Candida albicans at MIC and 2MIC, and (ii) free radical scavenging activity upon DPPH and ABTS assays. This novel contribution on the antimicrobial activity and potential mechanistic studies of C. nucifera-based nanoparticles and nanocomposite counterparts might allow a better understanding of the antimicrobial activity of these biomaterials. As it is essential that nanoscale materials be thoroughly characterized to ensure reproducibility in their fabrication, UV-vis spectrometry and FTIR analyses were used for the characterization of the as-prepared nanomaterials. However, major limitations of this study include the use of the latest generation of characterization techniques, such as TEM, XRD, among others as complement to provide a complete characterization of these nanomaterials. Nonetheless, to release a comprehensive characterization of the as-prepared nanomaterials, assessment of morphological features, such as surface charge and crystal structure and others using TEM and XRD analyses should be considered among the main perspectives to this work. Furthermore, pharmacokinetic and in vivo studies, as well as in-depth antimicrobial mechanisms of action should be investigated to warrant the successful utilization of these antimicrobial nanoscale materials.

6. Conclusions

This study reports the implication of Cocos nucifera-based nanomaterials in targeting bacterial or fungal systems by inhibiting the oxidative stress caused by selected bacteria and fungi. Thus, an eco-friendly method was used for the fabrication of nanoparticles using Cocos nucifera aqueous extract as capping and reducing agent. The as-prepared nanoparticles were further impregnated with activated carbon (prepared from Cocos nucifera) to afford the nanocomposite. To our knowledge, this is the first report on the biological synthesis of nanocomposite from Cocos nucifera aqueous extract-based nanoparticle and activated carbon. Moreover, the nanomaterials were characterized using UV–vis spectroscopy and Fourier Transform Infrared (FTIR) spectroscopy. Upon in vitro antimicrobial assays of the nanomaterials against a panel of selected bacterial and fungal strains, there was a significant decrease in the bacterial and fungal loads as evidenced by the low MIC range obtained for the nanoparticles (MIC range: 7.8125-250 μg/mL; SI range: >4 to >32; Vero cells) and the nanocomposite counterparts (MIC range: 31.25-250 μg/mL; SI range: >16 to >128; Vero cells). The time-kill kinetic studies of the antibacterial action against E. coli revealed bactericidal orientation at MIC and 2MIC, whereas antifungal action of the nanomaterials displayed a fungistatic trend vis-à-vis Candida albicans at these concentrations. The as-prepared nanomaterials exhibited antioxidant activity by scavenging free radicals of DPPH and ABTS. This novel research contribution has demonstrated the implication of Cocos nucifera-based nanomaterials in targeting bacterial or fungal systems that mediate free-radical damage or by inhibiting the oxidative impairment caused by selected bacteria and fungi, the most susceptible being Escherichia coli and Candida albicans, respectively.

Author Contributions

Conceptualization, P.K.L., J.N.N. and F.F.B; methodology, Z.Y.T., N.O.A., A.L.M., F.L.T.T., and B.-N.N.-D.; software, V.N., B.-N.N.-D., and F.L.T.T.; validation, P.K.L., J.N.N., and F.F.B.; formal analysis, Z.Y.T., F.L.T.T., N.O.A., A.L.M., B.P.K. and V.N.; investigation, Z.Y.T., F.L.T.T., N.O.A., A.L.M., B.-N.N.-D., B.P.K and V.N.; resources, P.K.L., J.N.N., B.P.K. and F.F.B; data curation, Z.Y.T., F.L.T.T., N.O.A., A.L.M., B.-N.N.-D. and V.N.; writing—original draft preparation, Z.Y.T., F.L.T.T. and V.N.; writing—review and editing, Z.Y.T. and B.P.K.; visualization, P.K.L., B.P.K. and J.N.N.; supervision, P.K.L., J.N.N. and F.F.B; project administration, P.K.L., J.N.N., B.P.K. and F.F.B; funding acquisition, P.K.L., B.P.K., J.N.N. and F.F.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was externally funded by the Yaounde-Bielefeld Bilateral Graduate School for Natural Products with Anti-parasite and Antibacterial Activity (YaBiNaPA) (grant number 57316173) and the Seeding Labs' Instrumental Access.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is available from the corresponding author upon reasonable request.

Acknowledgments

The authors would like to thank to the ‘‘Centre Hospitalier Universitaire’’ of Yaounde (Cameroon) and ‘‘Centre Pasteur’’ of Cameroon for providing the bacterial and fungal strains. This work recieved support from the Yaoundé-Bielefeld Bilateral Graduate School for Natural Products with Anti-parasite and Antibacterial Activity (YaBiNaPA) and the Seeding Labs' Instrumental Access.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. The World Health Organization (WHO). Infectious Diseases. The Fact Sheets 2024. Available online: https://www.emro.who.int/health-topics/infectious-diseases/index.html (accessed on 6 January 2024).
  2. Nii-Trebi, N.I. Emerging and neglected infectious diseases: Insights, advances, and challenges. Biomed. Res. Int. 2017, 2017, 5245021. [Google Scholar] [CrossRef]
  3. Kumwenda, P.; Adukwu, E.C.; Tabe, E.S.; Ujor, V.C.; Kamudumuli, P.S.; Ngwira, M.; Tsung, J.; Wu, S.; Chisale, M.R.O. Prevalence, distribution and antimicrobial susceptibility pattern of bacterial isolates from a tertiary Hospital in Malawi. BMC Infect. Dis. 2021, 21, 1–10. [Google Scholar] [CrossRef]
  4. Bongomin, F.; Gago, S.; Oladele, R.O.; Denning, D.W. Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi. 2017, 3, 57. [Google Scholar] [CrossRef]
  5. Kainz, K.; Bauer, M.A.; Madeo, F.; Carmona-gutierrez, D. Fungal infections in humans: the silent crisis. Microb. Cell 2022, 7, 143–145. [Google Scholar] [CrossRef] [PubMed]
  6. Pfavayi, L.T.; Denning, D.W.; Baker, S.; Sibanda, E.N.; Mutapi, F. Determining the burden of fungal infections in Zimbabwe. Sci.Rep. 2021, 1–13. [Google Scholar] [CrossRef]
  7. Mandengue, C.E.; Denning, D.W. The burden of serious fungal infections in Cameroon. J. Fungi. 2018, 4, 1–9. [Google Scholar] [CrossRef]
  8. Dall, C. Report highlights the deadly impact of bacterial infections. Antimicrobial Stewardship Public Health. CIDRAP. 2022. Available online: https://www.cidrap.umn.edu/antimicrobial-stewardship/report-highlights-deadly-impact-bacterial-infections (accessed on 21 January 2024).
  9. Muendlein, H. 2022. Bacterial infections caused most deaths in sub-Saharan Africa in 2019: Lancet. Available online: https://www.downtoearth.org.in/news/africa/bacterial-infections-caused-most-deaths-in-sub-saharan-africa-in-2019-lancet-86209#:~:text=Published%3A%20Monday%2028%20November%202022&text=Sub%2DSaharan%20Africa%20saw%20the,cause%20of%20death%20in%202019.
  10. Amvomo, N.L.D.; Sama, C.K.K.; Bouopda, R.; Minkeza, F.C.N.; Mbopda, L.P.; Tchoumi, C.L.Y.; Kenmoe, L.O.T.; Simeni, G.T.; Tolo, E.C.; Ngongang, R.; et al. Bacterial ecology and antibiotic susceptibility profile of isolated strains from surfaces and medical devices in some departments of the Jordan Medical Services, Cameroon: a descriptive cross-sectional study. PAMJ—One Health 2023, 11. [Google Scholar] [CrossRef]
  11. Giustarini, D.; Dalle-Donne, I.; Milzani, A.; Rossi, R. Oxidative stress induces a reversible flux of cysteine from tissues to blood in vivo in the rat. FEBS J. 2009, 276, 4946–4958. [Google Scholar] [CrossRef]
  12. Vona, R.; Pallotta, L.; Cappelletti, M.; Severi, C.; Matarrese, P. The impact of oxidative stress in human pathology: Focus on gastrointestinal disorders. Antioxidants 2021, 10, 201. [Google Scholar] [CrossRef]
  13. Novaes, R.D.; Teixeira, A.L.; de Miranda, A.S. Oxidative stress in microbial diseases: Pathogen, host, and therapeutics. Oxid. Med. Cell Longev. 2019, 2019, 8159562. [Google Scholar] [CrossRef]
  14. Gain, C.; Song, S.; Angtuaco, T.; Satta, S.; Kelesidis, T. The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front. Microbiol. 2023, 13, 1111930. [Google Scholar] [CrossRef]
  15. Jomova, K.; Raptova, R.; Alomar, S.Y.; Alwasel, S.H.; Nepovimova, E.; Kuca, K.; Valko, M. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch. Toxicol. 2023, 97, 2499–2574. [Google Scholar] [CrossRef]
  16. Segal, E.; Elad, D. Special issue: Treatments for fungal infections. J. Fungi 2018, 4, 135. [Google Scholar] [CrossRef]
  17. Leekha, S.; Terrell, C.L.; Edson, R.S. General principles of antimicrobial therapy. Mayo Clin. Proc. 2011, 86, 156–167. [Google Scholar] [CrossRef]
  18. Campitelli, M.; Zeineddine, N.; Samaha, G.; Maslak, S. Combination antifungal therapy: A review of current data. J. Clin. Med. Res. 2017, 9, 451–456. [Google Scholar] [CrossRef]
  19. Wahab, M.A.; Li, L.; Li, H.; Abdala, A. Silver nanoparticle-based nanocomposites for combating infectious pathogens: Recent advances and future prospects. Nanomaterials 2021, 11, 1–16. [Google Scholar] [CrossRef]
  20. Vaou, N.; Stavropoulou, E.; Voidarou, C.C.; Tsakris, Z.; Rozos, G.; Tsigalou, C.; Bezirtzoglou, E. Interactions between medical plant-derived bioactive compounds: Focus on antimicrobial combination effects. Antibiotics 2022, 11, 1014. [Google Scholar] [CrossRef]
  21. Nguimatsia, F.; Kenmogne, S.B.; Ngo Mback, M.N.L.; Kouamouo, J.; Nzenti Tchuitio, L.L.; Melogmo Dongmo, Y.K.; Jazet Dongmo, P.M. Antibacterial activities of the essential oil and hydroethanolic extract from Aeollanthus heliotropioides Oliv. Mediterr. J. Chem. 2021, 11, 95–103. [Google Scholar]
  22. Lima, E.B.; Sousa, C.N.; Meneses, L.N.; Ximenes, N.C.; Santos Júnior, M.A.; Vasconcelos, G.S.; Lima, N.B.; Patrocínio, M.C.; Macedo, D.; Vasconcelos, S.M. Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological review. Braz. J. Med. Biol. Res. 2015, 48, 953–964. [Google Scholar] [CrossRef]
  23. Jadimurthy, R.; Jagadish, S.; Nayak, S.C.; Kumar, S.; Mohan, C.D.; Rangappa, K.S. Phytochemicals as invaluable sources of potent antimicrobial agents to combat antibiotic resistance. Life 2023, 13, 948. [Google Scholar] [CrossRef]
  24. Patra, J.K.; Das, G.; Fraceto, L.F.; Campos, E.V.R.; del Pilar Rodriguez-Torres, M.; Acosta-Torres, L.S.; Diaz-Torres, L.A.; Grillo, R.; Swamy, M.K.; Sharma, S.; et al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnology 2018, 16, 71. [Google Scholar] [CrossRef]
  25. Sánchez-López, E.; Gomes, D.; Esteruelas, G.; Bonilla, L.; Lopez-Machado, A.L.; Galindo, R.; Cano, A.; Espina, M.; Ettcheto, M.; Camins, A.; Silva, A.M.; et al. Metal-based nanoparticles as antimicrobial agents: An overview. Nanomaterials 2020, 10, 292. [Google Scholar] [CrossRef]
  26. Taha, A.; Ben Aissa, M.; Da’na, E. Green synthesis of an activated carbon-supported Ag and ZnO nanocomposite for photocatalytic degradation and its antibacterial activities. Molecules 2020, 25, 1586. [Google Scholar] [PubMed]
  27. Franco, D.; Calabrese, G.; Guglielmino, S.P.P.; Conoci, S. Metal-based nanoparticles: antibacterial mechanisms and biomedical application. Microorganisms 2022, 10, 1778. [Google Scholar] [CrossRef]
  28. Javed, R.; Zia, M.; Naz, S.; Aisida, S.O.; Ain, N.-u.; Ao, Q. Role of capping agents in the application of nanoparticles in biomedicine and environmental remediation: recent trends and future prospects. J. Nanobiotechnology 2020, 18, 172. [Google Scholar] [CrossRef] [PubMed]
  29. Xulu, J.H.; Ndongwe, T.; Ezealisiji, K.M.; Tembu, V.J.; Mncwangi, N.P.; Witika, B.A.; Siwe-Noundou, X. The use of medicinal plant-derived metallic nanoparticles in theranostics. Pharmaceutics 2022, 14, 2437. [Google Scholar] [CrossRef]
  30. Ghazzy, A.; Naik, R.R.; Shakya, A.K. Metal-polymer nanocomposites: A promising approach to antibacterial materials. Polymers 2023, 15, 2167. [Google Scholar] [CrossRef]
  31. Pongener, C.; Kibami, D.; Rao, K.S.; Goswamee, R.L.; Sinha, D. Adsorption studies of fluoride by activated carbon prepared from Mucuna prurines plant. Biological Methods of Water Treatment. J. Water Chem. Technol. 2017, 39, 108–115. [Google Scholar] [CrossRef]
  32. Naphtali Odogu, A.; Daouda, K.; Paul, L.K.; Agbor Tabi, G.; Ngouateu Rene, L.; Nsami, N.J.; Mbadcam, K.K. Effect of doping activated carbon based Ricinodendron Heudelotti shells with AgNPs on the adsorption of indigo carmine and its antibacterial properties. Arab. J. Chem. 2020, 13, 5241–5253. [Google Scholar] [CrossRef]
  33. Das, G.; Shin, H.S.; Kumar, A.; Vishnuprasad, C.N.; Patra, J.K. Photo-mediated optimized synthesis of silver nanoparticles using the extracts of outer shell fibre of Cocos nucifera L. fruit and detection of its antioxidant, cytotoxicity and antibacterial potential. Saudi J. Biol. Sci. 2021, 28, 980–987. [Google Scholar] [CrossRef]
  34. Clinical Laboratory Standard Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition M07 A9; Clinical Laboratory Standard Institute, 2012; 29(2). [Google Scholar]
  35. Bowling, T.; Mercer, L.; Don, R.; Jacobs, R.; Nare, B. Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis. Int. J. Parasitol. Drugs Drug Resist. 2012, 2, 262–270. [Google Scholar] [CrossRef]
  36. Bassene, E. Initiation à la recherche sur les substances naturelles. Presse Universitaire de Dakar 2012. 147p.
  37. Khan, R.A.; Khan, M.R.; Sahreen, S.; Ahmed, M. Evaluation of phenolic contents and antioxidant activity of various solvent extracts of Sonchus asper (L.) Hill. Chem. Cent. J. 2012, 6, 12. [Google Scholar] [CrossRef]
  38. Sinsinwar, S.; Sarkar, M.K.; Suriya, K.R.; Nithyanand, P.; Vadivel, V. Use of agricultural waste (coconut shell) for the synthesis of silver nanoparticles and evaluation of their antibacterial activity against selected human pathogens. Microb. Pathog. 2018, 124, 30–37. [Google Scholar] [CrossRef]
  39. Alshehri, A.A.; Malik, M.A. Phytomediated photo-induced green synthesis of silver nanoparticles using Matricaria chamomilla L. and its catalytic activity against rhodamine B. Biomolecules 2020, 10, 1604. [Google Scholar] [CrossRef]
  40. Hano, C.; Abbasi, B.H. Plant-based green synthesis of nanoparticles: Production, characterization and applications. Biomolecules 2021, 12, 31. [Google Scholar] [CrossRef]
  41. Lee, I.; Park, J.Y.; Hong, K.; Son, J.H.; Kim, S.; Lee, J.L. The effect of localized surface Plasmon resonance on the emission colour change in organic light emitting diodes. Nanoscale 2016, 8, 6463–4647. [Google Scholar] [CrossRef]
  42. Rautela, A.; Rani, J.; Debnath, M. Green synthesis of silver nanoparticles from Tectona grandis seeds extract: characterization and mechanism of antimicrobial action on different microorganisms. J. Anal. Sci. Technol. 2019, 10, 1–7. [Google Scholar] [CrossRef]
  43. Paul, K.; Bag, B.G.; Samanta, K. Green coconut (Cocos nucifera Linn) shell extract mediated size controlled green synthesis of polyshaped gold nanoparticles and its application in catalysis. Appl. Nanosci. 2014, 4, 769–775. [Google Scholar] [CrossRef]
  44. Khalid Thebo, N.; Ahmed Simair, A.; Sughra Mangrio, G.; Ansari, K.; Ali Bhutto, A.; Lu, C.; Ali Sheikh, W. Antifungal potential and antioxidant efficacy in the shell extract of Cocos nucifera (L.) (Arecaceae) against pathogenic dermal mycosis. Medicines 2016, 3, 12. [Google Scholar] [CrossRef]
  45. Sulaeman, A.; Mathematics, F.; Sciences, N.; Bandung, I.T. Preliminary study of characterization of nanoparticles from coconut shell as filler agent in composites materials. MAYFEB J. Mater. Sci. 2016, 1, 1–9. [Google Scholar]
  46. Kumari, B.V.; Mani, R.; Asokan, B.R.; Balakrishnan, K.; Ramasamy, A.; Parthasarathi, R.; Kandasamy, C.; Govindaraj, R.; Vijayakumar, N.; Vijayakumar, S. Green synthesised silver nanoparticles using Anoectochilus elatus leaf extract: Characterisation and evaluation of antioxidant, anti-inflammatory, antidiabetic, and antimicrobial activities. J. Compos. Sci. 2023, 7, 453. [Google Scholar] [CrossRef]
  47. Franklin Loic, T.T.; Boniface, P.K.; Vincent, N.; Zuriatou, Y.T.; Yimgang, V.L.; Ndi, J.N.; Paul, K.L.; Fabrice, F.B. Biological synthesis and characterization of silver-doped nanocomposites: Antibacterial and mechanistic studies. Drugs Drug Candidates 2024, 3, 13–32. [Google Scholar] [CrossRef]
  48. Yahya, M.A.; Mansor, M.H.; Zolkarnaini, W.A.A.W.; Rusli, N.S.; Aminuddin, A.; Mohamad, K.; Sabhan, F.A.M.; Atik, A.A.A.; Ozair, L.N. A brief review on activated carbon derived from agriculture by-product. AIP Conf. Proc. 2018, 1972, 030023. [Google Scholar] [CrossRef]
  49. Mikhailova, E.O. Silver Nanoparticles: Mechanism of action and probable bio-application. J. Funct. Biomater. 2020, 11, 84. [Google Scholar] [CrossRef] [PubMed]
  50. Burchacka, E.; Pstrowska, K.; Bryk, M.; Maciejowski, F.; Kułażyński, M.; Chojnacka, K. The properties of activated carbons functionalized with an antibacterial agent and a new SufA protease inhibitor. Materials 2023, 16, 1263. [Google Scholar] [CrossRef]
  51. Alvarez-Galvan, Y.; Minofar, B.; Futera, Z.; Francoeur, M.; Jean-Marius, C.; Brehm, N.; Yacou, C.; Jauregui-Haza, U.J.; Gaspard, S. Adsorption of hexavalent chromium using activated carbon produced from Sargassum ssp.: Comparison between lab experiments and molecular dynamics simulations . Molecules 2022, 27, 6040. [Google Scholar] [CrossRef]
  52. Tamokou, J.D.D.; Mbaveng,, A.T.; Kuete, V. Antimicrobial Activities of African Medicinal Spices and Vegetables. In Medicinal Spices and Vegetables from Africa: Therapeutic Potential Against Metabolic, Inflammatory, Infectious and Systemic Diseases; 2017; pp. 207–237. [Google Scholar]
  53. Brice, R.P.; Boniface, P.K.; Eutrophe Le Doux, K.; Vincent, N.; Yanick Kevin, M.D.; Paul, K.L.; Fabrice, F.B. Extracts from Cardiospermum grandiflorum and Blighia welwitschii (Sapindaceae) reveal antibacterial activity against Shigella species. S. Afr. J. Bot. 2023, 164, 419–428. [Google Scholar] [CrossRef]
  54. Majoumouo, M.S.; Sibuyi, N.R.S.; Tincho, M.B.; Mbekou, M.; Boyom, F.F.; Meyer, M. Enhanced anti-bacterial activity of biogenic silver nanoparticles synthesized from Terminalia mantaly extracts. Int. J. Nanomed. 2019, 14, 9031–9046. [Google Scholar] [CrossRef]
  55. Villaño, D.; Fernández-Pachón, M.; Moyá, M.; Troncoso, A.; García-Parrilla, M. Radical scavenging ability of polyphenolic compounds towards DPPH free radical. Talanta 2007, 1, 230–235. [Google Scholar] [CrossRef]
  56. Flieger, J.; Franus, W.; Panek, R.; Szymańska-Chargot, M.; Flieger, W.; Flieger, M.; Kołodziej, P. Green synthesis of silver nanoparticles using natural extracts with proven antioxidant activity. Molecules 2021, 26, 4986. [Google Scholar] [CrossRef] [PubMed]
  57. Ahmed, M.; Marrez, D.A.; Abdelmoeen, N.M.; Mahmoud, E.A.; Abdel-Shakur Ali, M.; Decsi, K.; Tóth, Z. Studying the antioxidant and the antimicrobial activities of leaf successive extracts compared to the green-chemically synthesized silver nanoparticles and the crude aqueous extract from Azadirachta indica. Processes 2023, 11, 1644. [Google Scholar] [CrossRef]
  58. Ivanov, A.V.; Bartosch, B.; Isaguliants, M.G. Oxidative Stress in Infection and Consequent Disease. Oxid. Med. Cell Longev. 2017, 3496043. [Google Scholar] [CrossRef] [PubMed]
Preprints 97861 g001
Figure 1. Graphical representation of the preparation of extract, silver nanoparticles and nanocomposites from Cocos nucifera shells.
Figure 1. Graphical representation of the preparation of extract, silver nanoparticles and nanocomposites from Cocos nucifera shells.
Preprints 97861 g001
Preprints 97861 g002
Figure 2. UV–Vis spectra of Cocos nucifera extract (CNS) compared to that of nanoparticles (AgNP) and chemical reagent (AgNO3). AgNO3: silver nitrate; AgNP: silver nanoparticles; CNS: Cocos nucifera extract.
Figure 2. UV–Vis spectra of Cocos nucifera extract (CNS) compared to that of nanoparticles (AgNP) and chemical reagent (AgNO3). AgNO3: silver nitrate; AgNP: silver nanoparticles; CNS: Cocos nucifera extract.
Preprints 97861 g002
Preprints 97861 g003
Figure 3. FTIR spectra of nanoparticles and coconut shell (A) coconut shell, activated carbon and nanocomposites (B) prepared from Cocos nucifera aqueous extract. AC: activated carbon; CNS: Cocos nucifera extract; AgNC: silver nanocomposites; AgNPs: silver nanoparticles; FTIR: Fourier Transform Infrared Spectroscopy.
Figure 3. FTIR spectra of nanoparticles and coconut shell (A) coconut shell, activated carbon and nanocomposites (B) prepared from Cocos nucifera aqueous extract. AC: activated carbon; CNS: Cocos nucifera extract; AgNC: silver nanocomposites; AgNPs: silver nanoparticles; FTIR: Fourier Transform Infrared Spectroscopy.
Preprints 97861 g003
Preprints 97861 g004
Figure 4. Time-kill curves of various concentrations of silver nanocomposite (A) and nanoparticle (B) on Escherichia coli. Data are presented as the mean ± standard deviation. The graphs (curves) assigned to the stars are significantly different (p < 0.0001, Dunnet test); AgNC: 20 Mm of silver nanocomposite; AgNP: 20 Mm of silver nanoparticle; EC: Escherichia coli; NC: Negative control; PC: Positive control.
Figure 4. Time-kill curves of various concentrations of silver nanocomposite (A) and nanoparticle (B) on Escherichia coli. Data are presented as the mean ± standard deviation. The graphs (curves) assigned to the stars are significantly different (p < 0.0001, Dunnet test); AgNC: 20 Mm of silver nanocomposite; AgNP: 20 Mm of silver nanoparticle; EC: Escherichia coli; NC: Negative control; PC: Positive control.
Preprints 97861 g004
Preprints 97861 g005
Figure 5. Time-kill curves of various concentrations of silver nanocomposite (A) and nanoparticle (B) on Candida albicans. Data are presented as the mean ± standard deviation. The graphs (curves) assigned to the stars are significantly different (p < 0.0001, Dunnet test); AgNC: 20 Mm of silver nanocomposite; AgNP: 20 Mm of silver nanoparticle; CANR: Candida albicans; NC: Negative control; PC: Positive control.
Figure 5. Time-kill curves of various concentrations of silver nanocomposite (A) and nanoparticle (B) on Candida albicans. Data are presented as the mean ± standard deviation. The graphs (curves) assigned to the stars are significantly different (p < 0.0001, Dunnet test); AgNC: 20 Mm of silver nanocomposite; AgNP: 20 Mm of silver nanoparticle; CANR: Candida albicans; NC: Negative control; PC: Positive control.
Preprints 97861 g005
Table 1. List of bacterial and fungal strains used for antimicrobial studies.
Table 1. List of bacterial and fungal strains used for antimicrobial studies.
Bacterial/Fungal strains Acronym Reference number Supplier
Escherichia coli
Klebsiella pneumoniae 		E. coli
K. pneumoniae 		ATCC 25922
NR 41817		 ATCC
BEI Resources
Pseudomonas aeruginosa P. aeruginosa NR 48982 BEI Resources
Methicillin-resistant Staphylococcus aureus S. aureus ATCC 33591 BEI Resources
Escherichia coli
Klebsiella pneumoniae 		E. coli
K. pneumoniae 		ATCC 25922
NR 41817		 ATCC
BEI Resources
Pseudomonas aeruginosa P. aeruginosa NR 48982 BEI Resources
Methicillin-resistant Staphylococcus aureus S. aureus ATCC 33591 BEI Resources
Salmonella enteridis
Shigella flexneri
Shigella sonnei
Staphylococcus aureus 		S. enteridis
S. flexneri
S. sonnei
S. aureus 		Isolat
NR 518
NR 519
ATCC 43300		 CPC
BEI resources
BEI resources
ATCC
Candida albicans C. albicans CA NR-29456 BEI resources
Candida glabrata C. glabrata CG 100 BEI resources
Candida krusei C. krusei CK ATCC-1415 ATCC
Candida parapsilosis C. parapsilosis CP O31S BEI resources
Candida albicans C. albicans CA ATCC-14516 ATCC
Table 2. Minimum inhibitory concentrations of the nanomaterials on selected bacterial strains.
Table 2. Minimum inhibitory concentrations of the nanomaterials on selected bacterial strains.
Minimum inhibitory concentrations (µg/ml)
Bacteria EC SONR SA SFNR SAMR SE PANR KPNR
AgNC 5mM 62.5 125 62.5 250 250 250 125 62.5
AgNC 10mM 31.25 250 62.5 62.5 125 125 62.5 62.5
AgNC 20mM 31.25 62.5 31.25 31.25 62.5 31.25 31.25 62.5
AgNP 5mM 15.625 62.5 15.625 31.25 31.25 31.25 31.25 31.25
AgNP 10mM 15.625 62.5 15.625 31.25 15.625 125 15.625 31.25
AgNP 20mM 7.8125 15.625 15.625 31.25 31.25 62.5 31.25 31.25
Ciprofloxacin 0.078 0.078 0.039 0.078 0.078 0.156 0.078 0.039
EC: Escherichia coli; KPNR: Klepsiela pneumonia SAMR: Methicillin resistant Staphylococcus aureus; PANR: Pseudomonas aeruginosa; SE: Salmonella enteritidis; SFNR: Shigella flexneri; SONR: Shigella sonnei; SA: Staphylococcus aureus; AgNC 5 mM: 5 mM silver nanocomposite; AgNC 10 mM: 10 mM silver nanocomposite; AgNC 20 mM: 20 mM silver nanocomposite; AgNP 5 mM: 5 mM silver nanoparticle; AgNP 10 mM: 10 mM silver nanoparticle; AgNP 20 mM: 20 mM silver nanoparticle.
Table 3. Minimum inhibitory concentrations of the nanomaterials on selected fungal strains.
Table 3. Minimum inhibitory concentrations of the nanomaterials on selected fungal strains.
Minimum inhibitory concentrations (µg/ml)
Fungi CK CP CG CANR CA
AgNC 5 mM 125 62.5 250 62.5 250
AgNC 10 mM 250 62.5 125 62.5 125
AgNC 20 mM 31.25 62.5 62.5 31.25 31.25
AgNP 5 mM 125 125 125 125 31.25
AgNP 10 mM 62.5 125 62.5 62.5 15.625
AgNP 20 mM 31.250 62.5 7.812 7.812 15.625
Fluconazole 0.153 0.153 0.3825 0.153 0.765
CA: Candida albicans, CANR: Candida albicans, CG: Candida glabrata, CK: Candida krusei, CP: Candida parapsilosis.AgNC 5 mM: 5 mM silver nanocomposite; AgNC 10mM: 10mM silver nanocomposite; AgNC 20 mM: 20 mM silver nanocomposite; AgNP 5 mM: 5mM silver nanoparticle; AgNP 10 mM: 10 mM silver nanoparticle; AgNP 20 mM: 20 mM silver nanoparticle.
Table 4. Median cytotoxic concentrations.
Table 4. Median cytotoxic concentrations.
Nanomaterials CC50 (µg/ml)
AgNC 5 mM >1000
AgNC 10 mM >1000
AgNC 20 mM >1000
AgNP 5 mM >1000
AgNP 10 mM >1000
AgNP 20 mM 60.52 ± 0.070711
Podophyllotoxin 0.4 ± 0.1
AgNC 5mM: 5 mM of silver nanocomposite; AgNC 10 mM: 10 mM of silver nanocomposite; AgNC 20 mM: 20 mM of silver nanocomposite; AgNP 5 mM: 5 mM of silver nanoparticle; AgNP 10 mM: 10 mM of silver nanoparticle; AgNP 20 mM: 20 mM of silver nanoparticle.
Table 5. ABTS radical scavenging activities of the nanomaterials.
Table 5. ABTS radical scavenging activities of the nanomaterials.
Nanomaterials/ascorbic acid RSA50 (µg/mL) EC50 x 103 (µg/mol) ARP x 10-5 (mol/µg)
AgNC 5mM 53.855 ± 2.722a 15.387 ± 0.778a 6.619 ±1.703a
AgNC 10mM 8.2695± 0.353a 2.362 ± 0.101a 41.704± 8.765a
AgNC 20mM 6.586 ± 0.645a 1.883 ± 0.186a 55.055 ± 0.281a
AgNP 5mM >500 na na
AgNP 10mM >500 na na
AgNP 20mM >500 na na
Ascorbic acid 22.46 ± 2.729a 6.417 ± 0.779a 15.699 ± 0.19a
Along the line, values carrying the same letter superscripts are not significantly different (P≤0.001), Dunnett's multiple comparisons test. AgNC 5 mM: 5 mM silver of nanocomposite; AgNC 10 mM: 10 mM of silver nanocomposite; AgNC 20 mM: 20 mM of silver nanocomposite; AgNP 5 mM: 5 mM of silver nanoparticle; AgNP 10 mM: 10 mM of silver nanoparticle; AgNP 20 mM: 20 mM of silver nanoparticle, na: no activity.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Green Synthesis of Cocos nucifera-Based Nanomaterials and Mechanistic Basis of Their Antimicrobial Action.

Zuriatou Yajeh Tanka

et al.

,

2024

Multifaceted Applications of Silver Nanoparticles Synthesized from Marine Fungus Aspergillus flavus MK4: Antimicrobial, Anticancer, and Wound-Healing Properties

Mohamed H Al-Agamy

et al.

,

2023

Exploring the Antibacterial and Antibiofilm Efficacy of Silver Nanoparticles Biosynthesized Using Punica granatum Leaves

Monisha Singhal

et al.

,

2021

Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated